Eli Lilly and Co Stock

Eli Lilly and Co Employees 2025

Eli Lilly and Co Employees

33,625

Ticker

LLY

ISIN

US5324571083

WKN

858560

In 2025, Eli Lilly and Co employed 33,625 people, a 0% change from the 33,625 number of employees in the previous year.

Eli Lilly and Co Aktienanalyse

What does Eli Lilly and Co do?

Eli Lilly and Co. is a global biopharmaceutical company headquartered in Indianapolis, Indiana, USA. The company was founded in 1876 by Colonel Eli Lilly with the aim of manufacturing pharmaceutical products of the highest quality. Eli Lilly began his career in the pharmacy industry and opened his own pharmacy in Indianapolis in 1876. He quickly developed his own medications and eventually established Eli Lilly and Company in 1901. Over the years, the company has continued to evolve and expand its business into numerous areas. Eli Lilly is focused on biopharmaceutical research and development and operates in areas such as oncology, diabetes, neurology, and others. The company's main goal is to develop drugs that can change and improve lives. Eli Lilly invests a high percentage of its revenue into research and development every year. The company has several strategic business units, including human pharmaceuticals, animal pharmaceuticals, and oncology research. Eli Lilly is divided into five main divisions: diabetes, oncology, immunology, neurology, and animal health. The diabetes division focuses on manufacturing insulin products and glucose sensors for the treatment of type 1 and type 2 diabetes, as well as blood glucose meters and other diabetes products. The oncology division focuses on researching and developing drugs to treat cancer. The company currently has several compounds in clinical trials, including a new preparation for the treatment of breast cancer. The immunology division focuses on products for the treatment of autoimmune and inflammatory diseases, such as psoriasis. The neurology division focuses on researching and developing drugs to treat diseases of the nervous system, such as Alzheimer's. The animal health division focuses on animal health products, such as drugs for the treatment of infections in livestock and pets. Eli Lilly is primarily known for its insulin products and treatments in the field of oncology. Some of the company's most well-known products include Humalog, Forteo, Alimta, and Cymbalta. The effectiveness and compliance of the products are monitored by a quality and safety system to ensure that patients receive the highest quality medications. In conclusion, Eli Lilly and Co. is a company with a long history and a unique business model. The company specializes in developing high-quality pharmaceutical products and has continued to evolve since its founding. Eli Lilly has become a leader in various areas such as diabetes, oncology, immunology, neurology, and animal health. They are known for their insulin products and treatments in the field of oncology. The company remains committed to expanding its reach and presence globally and continues to develop innovative products that can improve and change people's lives. Eli Lilly and Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Eli Lilly and Co's Employee Base

Eli Lilly and Co's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Eli Lilly and Co's operational capacity and future potential.

Year-to-Year Comparison

Assessing Eli Lilly and Co's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Eli Lilly and Co's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Eli Lilly and Co’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Eli Lilly and Co stock

How many employees does Eli Lilly and Co have this year?

Eli Lilly and Co has 33,625 undefined employees this year.

How many employees did Eli Lilly and Co have compared to the previous year?

Compared to the previous year, Eli Lilly and Co had 0% more employees.

What impact did the number of employees have on the company Eli Lilly and Co?

The number of employees has a direct impact on the efficiency and productivity of Eli Lilly and Co. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Eli Lilly and Co?

The number of employees can also have an impact on investors of Eli Lilly and Co, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Eli Lilly and Co affect the company?

An increase in equity of Eli Lilly and Co can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Eli Lilly and Co's equity affect the company?

A reduction in equity of Eli Lilly and Co can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Eli Lilly and Co?

Some factors that can influence the equity of Eli Lilly and Co include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Eli Lilly and Co so important for investors?

The equity of Eli Lilly and Co is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Eli Lilly and Co influence the company?

The number of employees at Eli Lilly and Co can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Eli Lilly and Co evolved in recent years?

In recent years, the number of employees at Eli Lilly and Co has changed by 0.

How many employees does Eli Lilly and Co currently have?

Eli Lilly and Co currently has 33,625 undefined employees.

Why is the number of employees important for investors of Eli Lilly and Co?

The number of employees is important for investors of Eli Lilly and Co as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Eli Lilly and Co take to change the number of employees?

To change the number of employees, Eli Lilly and Co can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Eli Lilly and Co pay?

Over the past 12 months, Eli Lilly and Co paid a dividend of 5.2 USD . This corresponds to a dividend yield of about 0.67 %. For the coming 12 months, Eli Lilly and Co is expected to pay a dividend of 6.61 USD.

What is the dividend yield of Eli Lilly and Co?

The current dividend yield of Eli Lilly and Co is 0.67 %.

When does Eli Lilly and Co pay dividends?

Eli Lilly and Co pays a quarterly dividend. This is distributed in the months of December, March, June, September.

How secure is the dividend of Eli Lilly and Co?

Eli Lilly and Co paid dividends every year for the past 26 years.

What is the dividend of Eli Lilly and Co?

For the upcoming 12 months, dividends amounting to 6.61 USD are expected. This corresponds to a dividend yield of 0.86 %.

In which sector is Eli Lilly and Co located?

Eli Lilly and Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eli Lilly and Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eli Lilly and Co from 9/10/2025 amounting to 1.5 USD, you needed to have the stock in your portfolio before the ex-date on 8/15/2025.

When did Eli Lilly and Co pay the last dividend?

The last dividend was paid out on 9/10/2025.

What was the dividend of Eli Lilly and Co in the year 2024?

In the year 2024, Eli Lilly and Co distributed 4.52 USD as dividends.

In which currency does Eli Lilly and Co pay out the dividend?

The dividends of Eli Lilly and Co are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Eli Lilly and Co stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Eli Lilly and Co

Our stock analysis for Eli Lilly and Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eli Lilly and Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.